Literature DB >> 17610372

Human placenta-derived feeders support prolonged undifferentiated propagation of a human embryonic stem cell line, SNUhES3: comparison with human bone marrow-derived feeders.

Seok Jin Kim1, Chang Hee Song, Hwa Jung Sung, Young Do Yoo, Dong Ho Geum, Sun Hwa Park, Ji Hyun Yoo, Jee Hyun Oh, Hye Jin Shin, Sun Haeng Kim, Jun Suk Kim, Byung Soo Kim.   

Abstract

Co-culture of human embryonic stem (ES) cells on mouse fibroblast feeders is the commonly used method for in vitro expansion of human ES cells in an undifferentiated state. However, it has potential risks of pathogen transmission from animals; thus, human cell-derived feeders have been employed to minimize this problem. In this study, we compared human placenta-derived feeders with bone marrow to demonstrate its effectiveness as feeders for in vitro long-term culture of human ES cells. We cultured a human ES cell line, SNUhES3, on human placenta-derived mesenchymal stem cell feeders and compared their culture efficiency with human bone marrow-derived feeders and control group (mouse fibroblast feeders, STO). The mean number of human ES cell colonies was 166 +/- 35 in the placenta feeders; this was significantly higher than bone marrow-derived feeders (87 +/- 16, p < 0.05). We could propagate the culture of SNUhES3 on the placenta feeders past the 50th week similar to control group. During the culture, the maintenance of undifferentiated state of SNUhES3 was demonstrated by the expression of SSEA-4, TRA-1-81, TRA-1-60, and Oct-4. However, we failed to propagate the culture of human ES cells on the human bone marrow-derived feeders past the 5th week. The efficiency of embryoid body formation was similar between placenta and control group, indicating the preservation of differentiation ability. Thus, placenta-derived feeders are more efficient for the long-term in vitro culture of human ES cells than bone marrow-derived feeders suggesting the possible role of placenta as a source for human cell-derived feeders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17610372     DOI: 10.1089/scd.2006.0098

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  12 in total

1.  CXCR2 and its related ligands play a novel role in supporting the pluripotency and proliferation of human pluripotent stem cells.

Authors:  Ji-Hye Jung; Seung Jin Lee; JiHea Kim; SongHee Lee; Hwa-Jung Sung; Jungsuk An; Yong Park; Byung Soo Kim
Journal:  Stem Cells Dev       Date:  2014-12-23       Impact factor: 3.272

2.  A Novel Culture Model for Human Pluripotent Stem Cell Propagation on Gelatin in Placenta-conditioned Media.

Authors:  Ji-Hye Jung; Byung Soo Kim
Journal:  J Vis Exp       Date:  2015-08-03       Impact factor: 1.355

Review 3.  Placenta as a source of hematopoietic stem cells.

Authors:  Elaine Dzierzak; Catherine Robin
Journal:  Trends Mol Med       Date:  2010-06-30       Impact factor: 11.951

4.  Human Menstrual Blood-Derived Mesenchymal Cells as New Human Feeder Layer System for Human Embryonic Stem Cells.

Authors:  Danúbia Silva Dos Santos; Vanessa Carvalho Coelho de Oliveira; Karina Dutra Asensi; Leandro Vairo; Adriana Bastos Carvalho; Antonio Carlos Campos de Carvalho; Regina Coeli Dos Santos Goldenberg
Journal:  Cell Med       Date:  2014-03-03

5.  Stemness evaluation of mesenchymal stem cells from placentas according to developmental stage: comparison to those from adult bone marrow.

Authors:  Hwa Jung Sung; Soon Cheol Hong; Ji Hyun Yoo; Jee Hyun Oh; Hye Jin Shin; In Young Choi; Ki Hoon Ahn; Sun Haeng Kim; Yong Park; Byung Soo Kim
Journal:  J Korean Med Sci       Date:  2010-09-17       Impact factor: 2.153

Review 6.  Role of bioinspired polymers in determination of pluripotent stem cell fate.

Authors:  Sheena Abraham; Nikolai Eroshenko; Raj R Rao
Journal:  Regen Med       Date:  2009-07       Impact factor: 3.806

7.  Human placenta is a potent hematopoietic niche containing hematopoietic stem and progenitor cells throughout development.

Authors:  Catherine Robin; Karine Bollerot; Sandra Mendes; Esther Haak; Mihaela Crisan; Francesco Cerisoli; Ivoune Lauw; Polynikis Kaimakis; Ruud Jorna; Mark Vermeulen; Manfred Kayser; Reinier van der Linden; Parisa Imanirad; Monique Verstegen; Humaira Nawaz-Yousaf; Natalie Papazian; Eric Steegers; Tom Cupedo; Elaine Dzierzak
Journal:  Cell Stem Cell       Date:  2009-10-02       Impact factor: 24.633

Review 8.  Production of human pluripotent stem cell therapeutics under defined xeno-free conditions: progress and challenges.

Authors:  Yongjia Fan; Jincheng Wu; Preeti Ashok; Michael Hsiung; Emmanuel S Tzanakakis
Journal:  Stem Cell Rev Rep       Date:  2015-02       Impact factor: 5.739

9.  Differentiation of adipocytes and osteocytes from human adipose and placental mesenchymal stem cells.

Authors:  Zahra Mohammadi; Jalil Tavakkol Afshari; Mohammad Reza Keramati; Daryoush Hamidi Alamdari; Meysam Ganjibakhsh; Azam Moradi Zarmehri; Ali Jangjoo; Mohammad Hadi Sadeghian; Masoumeh Arab Ameri; Leila Moinzadeh
Journal:  Iran J Basic Med Sci       Date:  2015-03       Impact factor: 2.699

10.  Dosage and cell line dependent inhibitory effect of bFGF supplement in human pluripotent stem cell culture on inactivated human mesenchymal stem cells.

Authors:  Tara Quang; Maribel Marquez; Giselle Blanco; Yuanxiang Zhao
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.